Brief: Nuvectis Pharma Inc Reports Fiscal Year 2022 Financial Results And Business Highlights
07/03/2023 13:27
March 7 (Reuters) - Nuvectis Pharma Inc NVCT.O :
* NUVECTIS PHARMA, INC. REPORTS FISCAL YEAR 2022 FINANCIAL
RESULTS
AND BUSINESS HIGHLIGHTS
* NUVECTIS PHARMA INC - NXP900 IND SUBMISSION AND PHASE 1
STUDY
COMMENCEMENT EXPECTED IN 1H 2023
* NUVECTIS PHARMA INC - CASH, CASH EQUIVALENTS, AND
SHORT-TERM
INVESTMENTS WERE $20.0 MILLION AS OF DECEMBER 31, 2022
Source text for Eikon: ID:nGNX4QKyPp
Further company coverage: NVCT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nuvectis Pharma
See all newsNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Nuvectis Pharma Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Ciprocopan (NXP100) Receives Marketing Approval In China For The Treatment Of Patients With PNH Previously Untreated With Complement Inhibitors
U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin